Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025
According to the World Health Organization, more than 90% of individuals with diabetes are affected by type 2 diabetes, underscoring the urgent need for effective glucoselowering therapies
Thus, under conditions of limited oxygen availability, glucose would be a preferred substrate
Expanding the dataset to include more diverse and large-scale images may improve the models generalizability and robustness across different populations
US$ 21.02
US$ 28.41
US$ 21.87
US$ 28.49
US$ 21.51
US$ 21.66
US$ 20.74
US$ 27.43
